4/A: CareDx Director Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Form 4/A (Amendment)
William A. Hagstrom, a director of CareDx, Inc., filed an amendment to a Form 4 to correct the exercise price of a stock option granted on June 14, 2024.
Summary
- William A. Hagstrom, a director at CareDx, Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the exercise price of a stock option (right to buy) previously reported.
- The stock option was granted on June 14, 2024, with an exercise price of $14.19.
- The option allows Hagstrom to purchase 16,048 shares of CareDx common stock.
- The options vest monthly, with 1/12th of the shares vesting on July 14, 2024, and the remainder vesting monthly through June 14, 2025.
- The original filing was made on June 18, 2024.
Sentiment
Score: 6
Explanation: The document is a routine correction of a previously filed form, indicating standard corporate governance procedures. It doesn't inherently suggest positive or negative sentiment, but rather a neutral administrative action.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, and 10% owners) of a publicly traded company buy or sell shares of the company's stock. This filing is an amendment to correct a previously filed form.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of earliest transaction (stock option grant) |
| 06/14/2024 | Stock option granted with exercise price of $14.19 |
| 06/18/2024 | Date of original Form 4 filing |
| 07/14/2024 | First vesting date for the stock option (1/12th of shares) |
| 06/14/2025 | Final vesting date for the stock option |
| 06/24/2024 | Date of amended Form 4/A filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.